Lim, D. W., Kao, H., Suteja, L., Li, C. H., Quah, H. S., Tan, D. S., . . . MEDICINE. (2024). Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma. NATURE PORTFOLIO.
استشهاد بنمط شيكاغوLim, Darren Wan-Teck, et al. Clinical Efficacy and Biomarker Analysis of Dual PD-1/CTLA-4 Blockade in Recurrent/metastatic EBV-associated Nasopharyngeal Carcinoma. NATURE PORTFOLIO, 2024.
MLA استشهادLim, Darren Wan-Teck, et al. Clinical Efficacy and Biomarker Analysis of Dual PD-1/CTLA-4 Blockade in Recurrent/metastatic EBV-associated Nasopharyngeal Carcinoma. NATURE PORTFOLIO, 2024.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.